サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1375144

北米のラテラルフローアッセイ市場の2028年までの予測- 地域別分析- 製品タイプ、用途、技術、エンドユーザー別

North America Lateral Flow Assay Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, Technology, End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 179 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
北米のラテラルフローアッセイ市場の2028年までの予測- 地域別分析- 製品タイプ、用途、技術、エンドユーザー別
出版日: 2023年08月28日
発行: The Insight Partners
ページ情報: 英文 179 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のラテラルフローアッセイ市場は、2023年の37億7,147万米ドルから2028年には52億5,535万米ドルに成長すると予測されています。2023年から2028年までのCAGRは6.9%を記録すると推定されています。

家庭用アッセイキット使用の増加が北米ラテラルフローアッセイ市場を後押し

ラテラルフローアッセイ（LFA）は、複雑な混合物（生体サンプル）中の分析対象物（条件特異的生体分子）を検出するために設計された紙ベースの検査であり、サンプルは検査装置の指定された場所に置かれます。これらの検査では、5～30分以内に結果が得られます。ラテラルフローアッセイキットは様々な環境条件下で安定性を示し、保存期間も長くなっています。ラテラル・フロー・アッセイに基づく在宅検査では、ユーザーが自分で採取したサンプルを検査し、訓練を受けた医療専門家の助けを借りずに結果を得ることができます。これらの検査は一般に市販されています。妊娠検査キットは、家庭用ラテラル・フロー・アッセイの最も身近な例の一つです。これらの検査法は、感染症、心血管疾患、HIVのような汚名を着せられた疾患の診断のためにも設計されています。したがって、これらの疾患の有病率の上昇と在宅ヘルスケアにおけるラテラル・フロー・アッセイ検査の採用増加が、ラテラル・フロー・アッセイ市場の成長を牽引しています。COVID-19のパンデミックの間、多くの企業がSARS-CoV-2感染の診断のために家庭用ラテラルフローアッセイを導入しました。

2020年7月、BDはSARS-CoV-2感染を15分で検出するポータブルで迅速なポイントオブケア抗原検査を発売しました。

2020年8月、米国食品医薬品局（FDA）は、同疾患を検出する迅速検査であるAbbott BinaxNOW COVID-19 Ag Cardの緊急使用認可を発行しました。BinaxNOWはアボット社の実績あるラテラルフロー技術を使用しており、医療従事者が頻繁に大量検査を行う際に、親しみやすく信頼性の高い方法となっています。

北米ラテラルフローアッセイ市場概要

北米ラテラルフローアッセイ市場は米国、カナダ、メキシコに区分されます。2022年の市場シェアは米国が最大。北米の市場成長の背景には、さまざまな疾患の有病率の上昇、先進的な診断法の導入に対する政府の支援、市場参入企業による研究開発やその他の活動への取り組みの増加があります。また、診断技術の進歩も北米のラテラルフローアッセイ市場に利益をもたらしています。米国のラテラル・フロー・アッセイ市場の成長は、妊娠検査用の家庭用キットの需要が急増していることと、HIV感染、肝炎、ピロリ菌感染、COVID-19などの感染症の発生率が急速に増加していることに起因しています。ワシントン大学医学部によると、米国では年間2,000万人の女性が家庭での妊娠検査に頼っており、これがラテラルフローアッセイベースの妊娠検査キットの採用を後押ししています。さらに米国には、ポイントオブケア診断のための先進的な製品を開発するさまざまな企業があります。例えば、米国のバイオ・ラッド・ラボラトリーズは2020年4月、SARS-CoV-2に対する抗体を同定する血液ベースの免疫測定キットを発売しました。このように、米国を拠点とする企業が製造する革新的な製品や、同国における感染症患者の急増による診断件数の増加は、ラテラルフローアッセイ市場の成長を後押しするいくつかの要因となっています。

北米ラテラルフローアッセイ市場の収益と2028年までの予測（金額）

北米ラテラルフローアッセイ市場セグメンテーション

北米のラテラルフローアッセイ市場は、製品タイプ、用途、技術、エンドユーザー、国別に区分されます。

製品タイプ別では、北米のラテラルフローアッセイ市場はキット＆試薬とラテラルフローリーダーに区分されます。2023年の市場シェアはキット&試薬セグメントが大きいです。ラテラルフローリーダー市場は、ポータブル/ハンドヘルドリーダーとベンチトップリーダーに細分化されます。

アプリケーション別に見ると、北米のラテラルフローアッセイ市場は、臨床検査、動物診断、食品安全・環境検査、医薬品開発・品質検査に区分されます。2023年の市場シェアは、臨床検査分野が最大でした。動物用診断市場はコンパニオンアニマルと家畜に細分化されます。医薬品開発・品質検査分野の市場はさらに、感染症検査、心臓マーカー検査、妊娠・不妊検査、コレステロール検査／脂質プロファイル、乱用薬物検査、その他に細分化されます。

技術別に見ると、北米のラテラルフローアッセイ市場はサンドイッチアッセイ、競合アッセイ、マルチプレックス検出アッセイに区分されます。2023年にはサンドイッチアッセイセグメントが市場の最大シェアを占めています。

エンドユーザー別では、北米のラテラルフローアッセイ市場は、病院＆クリニック、製薬＆バイオテクノロジー企業、診断研究所、在宅医療、動物病院、その他に区分されます。病院＆クリニックセグメントが2023年に市場で最大シェアを占めました。

国別に見ると、北米のラテラルフローアッセイ市場は米国、カナダ、メキシコに区分されます。米国は2023年にこの地域の市場を独占しました。

Abbott Laboratories、Access Bio Inc、bioMerieux SA、Bio-Rad Laboratories Inc、Danaher Corp、Hoffmann-La Roche Ltd、Hologic Inc、Merck KGaA、Qiagen NV、Thermo Fisher Scientific Incが北米ラテラルフローアッセイ市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 北米ラテラルフローアッセイ市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米のラテラルフローアッセイ市場- 市場情勢

  • 北米のPEST分析
  • 専門家の見解

第5章 北米のラテラルフローアッセイ市場- 主要市場力学

  • 市場促進要因
    • 家庭用アッセイキットの使用の増加
    • ポイントオブケア検査の人気の高まり
  • 市場抑制要因
    • 手順の制限によるアッセイ結果の一貫性の欠如
  • 市場機会
    • ラテラルフローアッセイのアプリケーションの進化
  • 今後の動向
    • ラテラルフロー免疫測定におけるスマートフォンの使用とAIの統合
  • 影響分析

第6章 ラテラルフローアッセイ市場：北米分析

  • 北米ラテラルフローアッセイ市場の収益予測と分析

第7章 北米ラテラルフローアッセイ市場分析-製品タイプ別

  • キット＆試薬
  • ラテラルフローリーダー

第8章 北米ラテラルフローアッセイ市場分析-用途別

  • ラテラルフローアッセイの概要
  • 北米ラテラルフローアッセイ市場の用途別売上高シェア（2022年、2028年）
  • 臨床検査
  • 動物用診断薬
  • 食品安全と環境試験
  • 医薬品開発と品質試験

第9章 北米ラテラルフローアッセイ市場分析：技術別

  • サンドイッチアッセイ
  • 競合アッセイ
  • マルチプレックス検出アッセイ

第10章 北米ラテラルフローアッセイ市場の分析-エンドユーザー別

  • 病院・クリニック
  • 製薬・バイオテクノロジー企業
  • 診断研究所
  • 在宅医療
  • 動物病院
  • その他

第11章 北米ラテラルフローアッセイ市場：国別分析

    • 北米のラテラルフローアッセイ市場：国別、2022年・2028年（%）

第12章 北米のラテラルフローアッセイ市場-業界情勢

  • 北米ラテラルフローアッセイ市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第13章 企業プロファイル

  • Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Abbott Laboratories
  • Merck KGaA
  • Hologic Inc
  • Qiagen NV
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • Access Bio Inc
  • Danaher Corp

第14章 付録

図表

List Of Tables

  • Table 1. U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
  • Table 2. U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Lateral Flow Reader (US$ Mn)
  • Table 3. U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Application (US$ Mn)
  • Table 4. U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Clinical Testing (US$ Mn)
  • Table 5. U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Veterinary Diagnostics (US$ Mn)
  • Table 6. U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
  • Table 7. U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By End User (US$ Mn)
  • Table 8. Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
  • Table 9. Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Lateral Flow Reader (US$ Mn)
  • Table 10. Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Application (US$ Mn)
  • Table 11. Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Clinical Testing (US$ Mn)
  • Table 12. Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Veterinary Diagnostics (US$ Mn)
  • Table 13. Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
  • Table 14. Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By End User (US$ Mn)
  • Table 15. Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
  • Table 16. Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Lateral Flow Reader (US$ Mn)
  • Table 17. Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Application (US$ Mn)
  • Table 18. Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Clinical Testing (US$ Mn)
  • Table 19. Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Veterinary Diagnostics (US$ Mn)
  • Table 20. Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
  • Table 21. Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By End User (US$ Mn)
  • Table 22. Recent Inorganic Growth Strategies in the North America Lateral Flow Assay Market
  • Table 23. Recent Organic Growth Strategies in the North America Lateral Flow Assay Market
  • Table 24. Glossary of Terms, Pulmonary Function Testing Systems Market

List Of Figures

  • Figure 1. North America Lateral Flow Assay Market Segmentation
  • Figure 2. North America Lateral Flow Assay Market by Country
  • Figure 3. North America Lateral Flow Assay Market Overview
  • Figure 4. Kits and Reagents is The Largest Share of Product Type Segment in North America Lateral Flow Assay Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. North America Lateral Flow Assay Market Impact Analysis of Drivers and Restraints
  • Figure 9. North America Lateral Flow Assay Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. North America Lateral Flow Assay Market, by Product, 2022 & 2028 (%)
  • Figure 11. Kits & Reagents: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Lateral Flow Readers: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Portable/Handheld Reader: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Benchtop: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. North America Lateral Flow Assay Market Revenue Share, by Application (2022 and 2028)
  • Figure 16. Clinical Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Veterinary Diagnostics: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Companion Animal: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Livestock Animal: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Food Safety and Environment Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Drug Development and Quality Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Infectious Diseases Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Cardiac Market Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Pregnancy and Fertility Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Cholesterol Testing/Lipid Profile: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Drug of Abuse Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Others: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. North America Lateral Flow Assay Market, by Technology, 2022 & 2028 (%)
  • Figure 29. Process of Sandwich Lateral Flow Assay
  • Figure 30. Sandwich Assays: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Process of Competitive Lateral Flow Assay
  • Figure 32. Competitive Assays: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Multiplex Detection Assays: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. North America Lateral Flow Assay Market, by End User, 2022 & 2028 (%)
  • Figure 35. Hospitals & Clinics: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Pharmaceutical & Biotechnology Companies: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Diagnostic Laboratories: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Home Care: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Veterinary Clinics: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Others: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. North America Lateral Flow Assay Market, by Key Country Revenue (2022)(US$ Mn)
  • Figure 42. North America Lateral Flow Assay Market, By Country, 2022 & 2028 (%)
  • Figure 43. U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 44. Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 45. Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 46. Growth Strategies in the North America Lateral Flow Assay Market
目次
Product Code: BMIRE00028829

The North America lateral flow assay market is expected to grow from US$ 3,771.47 million in 2023 to US$ 5,255.35 million by 2028. It is estimated to record a CAGR of 6.9% from 2023 to 2028.

Increasing Use of Home-Based Assay Kits Fuels North America Lateral Flow Assay Market

Lateral flow assays (LFA) are paper-based tests designed for the detection of analytes (condition-specific biomolecules) in complex mixtures (biological samples), wherein samples are placed in a designated spot in a test device. These tests provide results within 5-30 minutes. Lateral flow assay kits exhibit stability over various environmental conditions and prolonged shelf life. Home tests based on lateral flow assays permit users to test self-collected samples and obtain results without the assistance of a trained medical professional. These tests are generally sold over the counter. A pregnancy test kit is one of the most familiar examples of home-based lateral flow assays. These assays are also designed for the diagnosis of infectious diseases, cardiovascular diseases, and stigmatized diseases such as HIV. Therefore, the rising prevalence of these diseases and the increasing adoption of lateral flow assay testing in home healthcare drive the lateral flow assay market growth. During the COVID-19 pandemic, many companies introduced at-home lateral flow assays for the diagnosis of SARS-CoV-2 infection due to people's reluctance to visit hospitals or diagnostic labs for testing.

In July 2020, BD Launched a portable, rapid point-of-care antigen test to detect SARS-CoV-2 infection in 15 minutes.

In August 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization for Abbott BinaxNOW COVID-19 Ag Card, a rapid test to detect the disease. BinaxNOW uses Abbott's proven lateral flow technology, making it a friendly and reliable method for frequent mass testing among healthcare providers.

North America Lateral Flow Assay Market Overview

The North America lateral flow assay market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2022. The market growth in North America is attributed to the rising prevalence of various diseases, government support for the adoption of advanced diagnostics, and increasing efforts in R&D and other activities undertaken by market players. In addition, technological advancements in diagnostics benefit the North America lateral flow assay market. The growth of the US lateral flow assay market is attributed to the burgeoning demand for at-home kits for pregnancy testing and the rapidly increasing incidence of infectious diseases, such as HIV infection, hepatitis, H. pylori infection, and COVID-19. According to the Washington University School of Medicine, ~20 million women in the US rely on home pregnancy tests annually, which boosts the adoption of lateral flow assay-based pregnancy test kits. Moreover, the US is home to various companies developing advanced products for point-of-care diagnosis. For instance, in April 2020, US-based Bio-Rad Laboratories launched a blood-based immunoassay kit to identify antibodies to SARS-CoV-2. Thus, the innovative products manufactured by the US-based players and increasing diagnoses due to rapidly rising cases of infectious diseases in the country are a few factors boosting the lateral flow assay market growth.

North America Lateral Flow Assay Market Revenue and Forecast to 2028 (US$ Million)

North America Lateral Flow Assay Market Segmentation

The North America lateral flow assay market is segmented on the basis of product type, application, technology, end user, and country.

Based on product type, the North America lateral flow assay market is segmented into kits & reagents and lateral flow readers. The kits & reagents segment held a larger share of the market in 2023. The market for lateral flow readers is sub-segmented into portable/handheld readers and benchtop readers.

Based on application, the North America lateral flow assay market is segmented into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The clinical testing segment held the largest share of the market in 2023. The market for veterinary diagnostics is sub-segmented into companion animals and livestock. The market for the drug development & quality testing segment is further segmented into infectious diseases testing, cardiac marker testing, pregnancy and fertility testing, cholesterol testing/ lipid profile, drug of abuse testing, and others.

Based on technology, the North America lateral flow assay market is segmented into sandwich assays, competitive assays, and multiplex detection assays. The sandwich assays segment held the largest share of the market in 2023.

Based on end user, the North America lateral flow assay market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, diagnostics laboratories, homecare, veterinary clinics, and others. The hospitals & clinics segment held the largest share of the market in 2023.

Based on country, the North America lateral flow assay market is segmented into the US, Canada, and Mexico. The US dominated the market in this region in 2023.

Abbott Laboratories, Access Bio Inc, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, Hoffmann-La Roche Ltd, Hologic Inc, Merck KGaA, Qiagen NV, and Thermo Fisher Scientific Inc are the leading companies operating in the North America lateral flow assay market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America lateral flow assay market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America lateral flow assay market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Lateral Flow Assay Market - by Product Type
    • 1.3.2 North America Lateral Flow Assay Market - by Application
    • 1.3.3 North America Lateral Flow Assay Market - by Technology
    • 1.3.4 North America Lateral Flow Assay Market - by End User
    • 1.3.5 North America Lateral Flow Assay Market - by Country

2. North America Lateral Flow Assay Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Lateral Flow Assay Market - Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis
  • 4.3 Expert's Opinion

5. North America Lateral Flow Assay Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Use of Home-Based Assay Kits
    • 5.1.2 Rising Popularity of Point-of-Care Testing
  • 5.2 Market Restraints
    • 5.2.1 Inconsistent Assay Results Due to Procedural Limitations
  • 5.3 Market Opportunities
    • 5.3.1 Evolving Applications of Lateral Flow Assays
  • 5.4 Future Trends
    • 5.4.1 Smartphone Usage and AI Integration in Lateral Flow Immunoassay
  • 5.5 Impact analysis

6. Lateral Flow Assay Market - North America Analysis

  • 6.1 North America Lateral Flow Assay Market Revenue Forecast and Analysis

7. North America Lateral Flow Assay Market Analysis - by Product Type

  • 7.1 Overview
  • 7.2 Kits & Reagents
    • 7.2.1 Overview
    • 7.2.2 Kits & Reagents: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.3 Lateral Flow Readers
    • 7.3.1 Overview
    • 7.3.2 Lateral Flow Readers: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.1 Portable/Handheld Reader
        • 7.3.2.1.1 Overview
        • 7.3.2.1.2 Portable/Handheld Reader: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.2 Benchtop
        • 7.3.2.2.1 Overview
        • 7.3.2.2.2 Benchtop: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Lateral Flow Assay Market Analysis - by Application

  • 8.1 Overview
  • 8.2 North America Lateral Flow Assay Market Revenue Share, by Application (2022 and 2028)
  • 8.3 Clinical Testing
    • 8.3.1 Overview
    • 8.3.2 Clinical Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Veterinary Diagnostics
    • 8.4.1 Overview
    • 8.4.2 Veterinary Diagnostics: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Companion Animal
      • 8.4.3.1 Overview
      • 8.4.3.2 Companion Animal: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.4 Livestock Animal
      • 8.4.4.1 Overview
      • 8.4.4.2 Livestock Animal: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Food Safety and Environment Testing
    • 8.5.1 Overview
    • 8.5.2 Food Safety and Environment Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Drug Development and Quality Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Development and Quality Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.6.3 Infectious Diseases Testing
      • 8.6.3.1 Overview
      • 8.6.3.2 Infectious Diseases Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.6.4 Cardiac Marker Testing
      • 8.6.4.1 Overview
      • 8.6.4.2 Cardiac Market Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.6.5 Pregnancy and Fertility Testing
      • 8.6.5.1 Overview
      • 8.6.5.2 Pregnancy and Fertility Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.6.6 Cholesterol Testing/Lipid Profile
      • 8.6.6.1 Overview
      • 8.6.6.2 Cholesterol Testing/Lipid Profile: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.6.7 Drug of Abuse Testing
      • 8.6.7.1 Overview
      • 8.6.7.2 Drug of Abuse Testing: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.6.8 Others
      • 8.6.8.1 Overview
      • 8.6.8.2 Others: North America Lateral Flow Assay Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Lateral Flow Assay Market Analysis - by Technology

  • 9.1 Overview
  • 9.2 Sandwich Assays
    • 9.2.1 Overview
    • 9.2.2 Sandwich Assays: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.3 Competitive Assays
    • 9.3.1 Overview
    • 9.3.2 Competitive Assays: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Multiplex Detection Assays
    • 9.4.1 Overview
    • 9.4.2 Multiplex Detection Assays: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Lateral Flow Assay Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospitals & Clinics
    • 10.2.1 Overview
    • 10.2.2 Hospitals & Clinics: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.3 Pharmaceutical & Biotechnology Companies
    • 10.3.1 Overview
    • 10.3.2 Pharmaceutical & Biotechnology Companies: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Diagnostic Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostic Laboratories: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Home Care
    • 10.5.1 Overview
    • 10.5.2 Home Care: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.6 Veterinary Clinics
    • 10.6.1 Overview
    • 10.6.2 Veterinary Clinics: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.7 Others
    • 10.7.1 Overview
    • 10.7.2 Others: North America Lateral Flow Assays Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Lateral Flow Assay Market Country Analysis

  • 11.1 Overview
    • 11.1.1 North America Lateral Flow Assay Market, By Country, 2022 & 2028 (%)
      • 11.1.1.1 U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.1.1.1.1 U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.1.1.1.2 U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
        • 11.1.1.1.2.1 U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Lateral Flow Reader (US$ Mn)
        • 11.1.1.1.2.2 U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Application (US$ Mn)
        • 11.1.1.1.3 U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Clinical Testing (US$ Mn)
        • 11.1.1.1.4 U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Veterinary Diagnostics (US$ Mn)
        • 11.1.1.1.5 U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
        • 11.1.1.1.6 U.S.: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By End User (US$ Mn)
      • 11.1.1.2 Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.1.1.2.1 Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.1.1.2.2 Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
        • 11.1.1.2.2.1 Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Lateral Flow Reader (US$ Mn)
        • 11.1.1.2.2.2 Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Application (US$ Mn)
        • 11.1.1.2.3 Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Clinical Testing (US$ Mn)
        • 11.1.1.2.4 Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Veterinary Diagnostics (US$ Mn)
        • 11.1.1.2.5 Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
        • 11.1.1.2.6 Canada: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By End User (US$ Mn)
      • 11.1.1.3 Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.1.1.3.1 Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.1.1.3.2 Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
        • 11.1.1.3.2.1 Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Lateral Flow Reader (US$ Mn)
        • 11.1.1.3.2.2 Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Application (US$ Mn)
        • 11.1.1.3.3 Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Clinical Testing (US$ Mn)
        • 11.1.1.3.4 Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Veterinary Diagnostics (US$ Mn)
        • 11.1.1.3.5 Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
        • 11.1.1.3.6 Mexico: North America Lateral Flow Assay Market Revenue and Forecasts to 2028, By End User (US$ Mn)

12. North America Lateral Flow Assay Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the North America Lateral Flow Assay Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profile

  • 13.1 Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Thermo Fisher Scientific Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Abbott Laboratories
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Merck KGaA
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Hologic Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Qiagen NV
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 bioMerieux SA
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Bio-Rad Laboratories Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Access Bio Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Danaher Corp
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms